MedPath

Virtual Reality in Laryngology

Not Applicable
Completed
Conditions
Pain Management During Office Laryngeal Procedures
Registration Number
NCT05218967
Lead Sponsor
Weill Medical College of Cornell University
Brief Summary

The purpose of this study is to compare patient's pain and anxiety undergoing laryngeal procedures and esophageal manometry while wearing a VR headset to standard of care. It is hypothesized that patient's using the VR headset during the procedure will have reduced pain and anxiety as compared to their standard of care counterparts because the VR environment will distract them from their procedure.

Detailed Description

This is a prospective randomized controlled trial, comparing patients' pain and anxiety experience while wearing a VR headset and receiving standard analgesia during In-office aerodigestive procedures (IOAEP) to patients' experience receiving standard analgesia only during IOAEP.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Adult patients (18 or older)
  • Patients scheduled for IOAEP, including laryngeal biopsies, percutaneous injection laryngoplasty, KTP ablation of hemorrhagic polyps and respiratory papilloma, and transnasal esophagoscopy (TNE), and esophageal manometry.
Exclusion Criteria
  • Patients under 18 years of age
  • Patients unable to consent
  • Non-English-speaking patients
  • Patients who have undergone prior IOAEP
  • Patients who have used any psychotropic or analgesic medication within the last 24 hours due to the possible confounding effect on pain or anxiety perception
  • Patients with motion sickness or uncorrected visual impairment (legal blindness)
  • Patients with past medical history of seizures or visual abnormalities

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Physician QuestionnaireImmediately After Procedure

Clinicians will fill out a short 6 question survey about the use of VR during their procedure. The survey is a short 6 item questionnaire inquiring about difficulty and success of the procedure, perceived patients' discomfort, observed patient agitation, interference and benefit of the VR headset. These questions will be answered using a Likert scale ranging from 1 (strongly disagree) to 5 (strongly agree).

Galvanic Skin ActivityMeasures will be recorded immediately before and immediately after the procedure.

Galvanic Skin Activity will be measured through AD instruments PowerLab

Anxiety during the procedure , as measured by the spielberger State-Trait Anxiety Inventory (SF- STAI)During Procedure

The STAI consists of 6 questions concerning patient's current state of anxiety with responses ranging from (1) never to almost always (4).

Pain during procedure, as measured by the McGill Pain QuestionnaireDuring Procedure

individually rated pain descriptors with 11 addressing sensory pain and 4 focusing on affective components of pain. Each item is rated on a 4-point scale that ranges from none to severe.

Heart rateMeasures will be recorded immediately before and immediately after the procedure.

Heart rate will will be measured through AD instruments PowerLab.

TemperatureMeasures will be recorded immediately before and immediately after the procedure.

Temperature will be measured through AD instruments PowerLab

Pain as measured by the Visual Analog ScaleMeasures will be recorded immediately after the procedure.

Visual Analog Pain Scale measured pain on range from 0-100 (0 is no pain and 100 is max pain) about time of pain, unpleasantness, average pain, and worst pain on a scale of 0-100.

Upper Esophageal Sphincter PressureDuring the Procedure

Upper Esophageal Sphincter Pressure will be measured through the probe inserted during the High Resolution Manometry

Post Procedure Patient QuestionnaireImmediately After Procedure

Patients will be asked if they would repeat the procedure again on a scale of 1-5 with 1 being never and 5 being always.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Weill Cornell Medicine

🇺🇸

New York, New York, United States

Weill Cornell Medicine
🇺🇸New York, New York, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.